Inovio Pharmaceuticals (INO) Reports Mixed Q3 Results
Tweet
Share
E-mailGet Alerts INO Hot Sheet
Price: $1.24 --0%
EPS Growth %: +75.9%
Financial Fact:
Net loss: -20.76M
Today's EPS Names:
ALZN, ASPU, OCCI, More
EPS Growth %: +75.9%
Financial Fact:
Net loss: -20.76M
Today's EPS Names:
ALZN, ASPU, OCCI, More
Join SI Premium – FREE
Inovio Pharmaceuticals, Inc. (AMEX: INO) reported Q3 EPS of ($0.04), $0.01 worse than the analyst estimate of ($0.03). Revenue for the quarter came in at $2.64 million versus the consensus estimate of $1.87 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Lennar Corp. (LEN) Misses Q3 EPS by 10c
- Vera Bradley (VRA) Tops Q2 EPS by 10c ; Offers Guidance
- Dave & Buster's Entertainment (PLAY) Misses Q2 EPS by 46c
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
